Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Xenon Pharmaceuticals Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $1.21B | $836.23M - $2.02B | -$241.17M | $4.223 | 13 |
| Dec 2029 | $781.51M | $541.96M - $1.31B | -$156.30M | $1.00 | 9 |
| Dec 2028 | $279.33M | $269.87M - $288.79M | -$55.87M | -$3.339 | 14 |
| Dec 2027 | $57.05M | $27.99M - $120.83M | -$11.41M | -$4.933 | 12 |
| Dec 2026 | $2.07M | $1.43M - $3.46M | -$413.1K | -$4.779 | 11 |
| Dec 2025 | $7.58M | $7.41M - $8.67M | -$1.52M | -$4.247 | 14 |
| Dec 2024 | $312.5K | $216.7K - $522.7K | -$62.5K | -$3.097 | 8 |
| Dec 2023 | $2.20M | $2.13M - $2.26M | -$382.1K | -$2.827 | 16 |
| Dec 2022 | $12.16M | $2.77M - $29.77M | -$2.11M | -$2.086 | 7 |
| Dec 2021 | $20.72M | $4.71M - $50.73M | -$3.60M | -$1.658 | 7 |
| Dec 2020 | $30.22M | $6.87M - $73.98M | -$5.25M | -$0.871 | 6 |
| Dec 2019 | $3.50M | $796.0K - $8.57M | -$608.6K | -$1.63 | 4 |